Search

METEOR’s search works in a similar way to other search engines. You can use keywords or terms to pull up related content. The below tips are specific to METEOR and will help you to find what you need.

Try searching using either a keyword, specific term or METEOR ID number.

METEOR ID search

If you’re a returning user and know an item’s METEOR ID, you can enter it in the search box. Clicking the search icon will take you straight to the item’s page.

Autocomplete

METEOR will automatically display suggestions for search terms as you’re typing. This predictive text will show you METEOR entries that exist for the topic you’re searching on. You don’t have to use any of these suggestions, but they may make your searching process faster and easier.

Pressing ‘tab’ will select the top suggestion. Otherwise, selecting from the list of suggestions will put the suggested search term into the search box. You can then click the search icon to find related content. Clicking anywhere on the search results will take you to the item’s page.

Spelling correction

METEOR will show search results with spelling correction. Misspelled terms can still be selected for search where relevant.

Dropdown options

The drop-down menus directly below the search text box allow you to limit the search results to any of the 18 content types in METEOR (see Learn about metadata to view the list), by item creation dates, and item revision dates.

Content types

Content types allow you to limit your search to various metadata building blocks and other topic or help content found in METEOR. See Learn about metadata to view a list of metadata item types that you can search in METEOR. Searching on Topic pages will give results from METEOR’s ‘non-metadata’ pages which explain metadata, how it is managed, how to use METEOR, and how to develop metadata.

Searching on Help will give results from all the pop-up information boxes that are linked to each metadata item. The Help search looks through all text from the METEOR Business Rules, which is accessed through the small ‘i’ icon used throughout the site.

Created date and Revision date

The Created and Revision date dropdown options limit your search to when an item was created or last revised. METEOR will search any time by default, or you can select or specify a custom period.

Custom search syntax

METEOR uses Lucene search syntax. This functionality can be useful to fine-tune your search results even more. Some of the commands include:

  1. Restrict search to the titles of items by using Name: Searchterm. Note that it has to be written exactly as Name, with the capital N. Using name will not work. It doesn’t matter if there’s a space around the colon or not.
  2. Force a second term to be included by using AND.
  3. Widen your search to include another option using the term OR.

For example, if you’re looking for something with the word ‘baby’ in the title you would use Name: baby. METEOR will also give you results for the plural of the search term, so if you search on ‘baby’ you will also get results for ‘babies’. If looking for something with two terms (‘baby’ and ‘admission’) you would use Name: baby AND admission.

Sort by

You can also display your search results with a range of options in the Sort by drop-down menu on the right. You can sort on Relevance, Most/Least Recently Created, Most/Least Recently Updated, and Alphabetically (A–Z and Z–A).

Clear

The Clear button resets the Search page.

Filtering search results

You can fine-tune your search results using the filters that appear in the left-hand menu after searching any term. These filters are dynamic and will only display options specific to your search term, for example, only registration authorities relating to your search term will be displayed. You can use multiple filters at once.

Some of the filters change depending on your role within METEOR. If you are using METEOR without an account, you can search on metadata item type, public registration statuses, METEOR ID, and registration authority. You are also able to compare two items.

If you are using METEOR without an account, you will not be able to save bookmarks for items you’re interested in. There are also some non-public registration statuses that you won’t be able to see.

If you wish to save bookmarks, you can sign up for a free METEOR account easily, just follow the Sign up now prompts after clicking on the Sign In button. If you have an account, you will also be able to subscribe to notifications about changes to specific items in METEOR.

If you are logged in to METEOR as a metadata developer, or any other official role, there are some additional search options. You will be able to restrict your search to the full range of registration status options, including non-public statuses. You will also be able to save bookmarks and subscribe to notifications about changes to items.

Each search result has a small ‘hamburger’ icon on the right . This gives you download links for the metadata item as a PDF or a Word document.


Search

Showing 1-100 of 134 results
2 Next
Page size:
Radiotherapy target site

414605 | Property | Cancer Australia
The site or region of the body where radiotherapy is administered. Radiotherapy is the treatment of disease by means of ionizing radiation.
Standard: Health

Cytopathology result

425016 | Property | Cancer Australia
The result of the microscopic analysis of cells for the purpose of disease diagnosis.
Standard: Health

Multidisciplinary team review indicator

428242 | Property | Cancer Australia
An indicator of whether a patient's treatment was discussed and planned at a multidisciplinary team meeting. The multidisciplinary team should consist of the core disciplines required for the provision of good patient care, which will vary by disease type.
Standard: Health

Care coordinator assignment indicator

467844 | Property | Cancer Australia
An indicator of whether a care coordinator has been assigned. The role of a care coordinator is to achieve continuity of care and to ensure that care is delivered in a timely, logical and connected fashion so that both medical and personal needs are met.The assignment of a care coordinator is an indicator of the method of care that is being received.
Standard: Health

Research trial type

458189 | Property | Cancer Australia
The type of trial or research study. This includes clinical trials, supportive care trials/studies and other research studies. The type of trial is indicative of the focus of the trial and the potential way that the trial may effect a participant.
Standard: Health

Lymphovascular invasion indicator

519205 | Property | Cancer Australia
An indicator of whether there is evidence of the invasion of cancer cells into blood vessels and/or the lymphatic system in the pathology specimen.
Standard: Health

Residual (R) tumour type

521148 | Property | Cancer Australia
The type of residual tumour left after the initial course of treatment.
Standard: Health

Specialist support services type

566644 | Property | Cancer Australia
The type of specialist support services as part of a patient's treatment regime. Specialist support services are those that do not target the primary disease but help to manage side effects, symptoms, late effects and quality of life. Specialist support services include community services, allied health services and other hospital support service, such as the use of psychiatrists, psychologists, physiotherapists, social workers, specialist nurses/nurse counsellors, cancer support or volunteer su...
Standard: Health

Fertility preservation utilised indicator

567511 | Property | Cancer Australia
An indicator of whether tissue preserved for purpose of fertility has been used.
Standard: Health

Fertility counselling provided indicator

567309 | Property | Cancer Australia
An indicator of whether fertility counselling was provided. This includes counselling about the potential outcomes that a disease, disorder or treatment can have on their long term fertility and the options that they have in relation to fertility preservation or treatment options that may have a reduced impact on their fertility.
Standard: Health

Extraprostatic extension location

587664 | Property | Cancer Australia
The location of extraprostatic extension (EPE) on the prostate.
Standard: Health

Extraprostatic extension indicator

587667 | Property | Cancer Australia
An indicator of the presence of extraprostatic extension (EPE) on the prostate.
Standard: Health

Clinical trial funding basis

467776 | Property | Cancer Australia
Whether a clinical trial is funded academically or by industry. Academic funding includes funding from academic institutions or government entities. Industry funding includes funding through private companies that are involved in the provision of pharmaceuticals or equipment that is used for clinical purposes.
Standard: Health

Supportive care trial name

458230 | Property | Cancer Australia
The name of the supportive care trial or study.Information regarding the types of supportive care trials/studies patients are enrolled in may have implications for access to, and the provision of, health services. Supportive care trials may take place after the completion of primary treatment.
Standard: Health

Urine voiding problem severity

495121 | Property | Cancer Australia
The severity of urine voiding problems.
Standard: Health

Molecular pathology test date

519350 | Property | Cancer Australia
The date on which a molecular pathology test is performed to determine the characteristics of a person's medical condition.
Standard: Health

Radiotherapy completion date

394467 | Property | Cancer Australia
The date on which radiotherapy was completed. Radiotherapy is the treatment of disease by means of ionizing radiation.
Standard: Health

Clinical trial identifier

430961 | Property | Cancer Australia
The scientific/public title and/or registration number used to identify clinical trial(s).
Standard: Health

Urinary incontinence pad use indicator

587643 | Property | Cancer Australia
An indicator of whether a person who is experiencing urinary incontinence is using pads to manage urine leakage.
Standard: Health

Primary course of chemotherapy delay indicator

542946 | Property | Cancer Australia
An indicator of whether the primary course of chemotherapy has been delayed.
Standard: Health

Date clinical trial entered

447311 | Property | Cancer Australia
The date on which a patient registers for a clinical trial.
Standard: Health

Tumour outside primary site indicator

545378 | Property | Cancer Australia
An indicator of whether there is macroscopic evidence of a tumour outside of the primary site of cancer.
Standard: Health

Immunotherapy start date

393536 | Property | Cancer Australia
The date on which immunotherapy commenced. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Date of last contact

394052 | Property | Cancer Australia
The date of the most recent contact with the patient.
Standard: Health

Diagnostic histology indicator

487260 | Property | Cancer Australia
An indicator of whether a tissue specimen was collected and examined histologically.
Standard: Health

Castrate resistance indicator

492861 | Property | Cancer Australia
An indicator outlining whether a rising prostate-specific antigen (PSA) level, or continued progression of prostate cancer despite castrate levels of testosterone, has been found.
Standard: Health

Adverse event grade

467445 | Property | Cancer Australia
The grade/severity of any adverse event experienced during the course of clinical care.
Standard: Health

Date of initial primary health care consultation

456982 | Property | Cancer Australia
The date of the initial consultation with a general practitioner or primary health care practitioner in relation to a specific disease-related symptom or where the instance of a specific disease was first suspected.
Standard: Health

Unintentional weight loss indicator

428806 | Property | Cancer Australia
An indicator of whether a person experienced unintentional weight loss of greater than 10% in the previous six months. Weight loss is a reduction of the total body mass, due to a mean loss of fluid, body fat or adipose tissue and/or lean mass. It can occur unintentionally due to an underlying disease such as cancer. Patients with medical causes of weight loss usually have signs or symptoms that suggest involvement of a particular organ system.
Standard: Health

Perineural invasion indicator

429128 | Property | Cancer Australia
An indicator of whether perineural invasion is evident in a pathology specimen.Perineural invasion refers to cancer cells tracking along or around a nerve within the space surrounding a nerve.
Standard: Health

Referral to palliative care services indicator

431267 | Property | Cancer Australia
An indicator of whether a patient has been referred to palliative care services. Referral to palliative care services is referral to palliative care administered by palliative care specialists such as a palliative care team or palliative physician. Palliative care may be administered in a community setting, for example, the patient's home or a nursing home, in the palliative care unit of an acute hospital or a hospice.
Standard: Health

Immediate/short term treatment complication indicator

581057 | Property | Cancer Australia
An indicator of the presence of an immediate or short-term treatment complication (adverse event) during clinical care.This includes, but is not limited to, complications from surgical treatment, such as an unplanned return to theatre, infection or haemorrhage, or complication from drug treatment, such as hypertension or toxicity.
Standard: Health

Diagnostic imaging type

431739 | Property | Cancer Australia
The type of medical imaging performed to confirm the diagnosis and determine the nature of a specific disease or condition.
Standard: Health

Core biopsy tumour length

587543 | Property | Cancer Australia
The total length of tissue involved by cancerous tissue in a single specimen found in pathology testing of tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Radiotherapy fractions administered

393508 | Property | Cancer Australia
The number of radiotherapy fractions or treatment sessions administered. Radiotherapy is the treatment of disease by means of ionizing radiation. Administration of the total dose of radiation is spread out over time and delivered to the patient in a number of even parts or treatment sessions (fractions). Although a treatment session may include several treatment portals delivered within a confined period of time, usually a few minutes, it is still considered one fraction.
Standard: Health

Hormone therapy start date

393523 | Property | Cancer Australia
The date on which hormone therapy commenced. The treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Surgery target site

413947 | Property | Cancer Australia
The anatomical location or site in the body where surgery is performed. Surgery is the treatment of disease, injury and deformity by physical operation or manipulation.
Standard: Health

Reason(s) second-line treatment administered

457424 | Property | Cancer Australia
The reason(s) second-line treatment, treatment that was not part of the planned initial course of treatment, was administered.
Standard: Health

Hereditary genetic events type

564417 | Property | Cancer Australia
The type of genetic mutation that is passed down to further generations in a biological family.
Standard: Health

Date of cancer staging

568595 | Property | Cancer Australia
The date on which cancer staging is completed.Cancer staging is a system of determining the extent or stage of cancer. This date should be equal to the date that the latest pathological or clinical testing required to determine staging occurred. Should the staging be based on surgical findings the date should be equal to the date of the relevant surgery.
Standard: Health

Referral to psychosocial services indicator

431244 | Property | Cancer Australia
An indicator of whether a patient has been referred to psychosocial services. The psychosocial needs of patients vary with their circumstances; however, most patients will experience some degree of practical, psychological and emotional challenges as a result of their diagnosis and treatment-related adverse effects. For instance, patients undergoing treatment may experience fear, anxiety and depression, while managing the demands of work and family with the demands of treatment may create enormo...
Standard: Health

Specialist support services date

587584 | Property | Cancer Australia
The date that specialist support services were used as part of a patient's treatment regime. Specialist support services are those that do not target the primary disease but help to manage side effects, symptoms, late effects and quality of life.Specialist support services include community services, allied health services and other hospital support service, such as the use of psychiatrists, psychologists, physiotherapists, social workers, specialist nurses/nurse counsellors, cancer support or v...
Standard: Health

Date of referral to palliative care services

448608 | Property | Cancer Australia
The date a patient is referred to palliative care services. Palliative care is defined as the active total care of patients whose disease is not responsive to curative treatment and may include the control of pain and other symptoms, and of psychological, social and spiritual support. Referral to palliative care services is referral to palliative care administered by palliative care specialists such as a palliative care team or palliative physician. Palliative care may be administered in a com...
Standard: Health

Pregnancy outcome indicator

593393 | Property | Cancer Australia
An indicator of whether a person or if male, their partner, has carried a pregnancy to term, including a live birth.
Standard: Health

Erectile dysfunction extent

598105 | Property | Cancer Australia
The degree of erectile dysfunction experienced.
Standard: Health

Systemic therapy procedure date

394639 | Property | Cancer Australia
The date on which a systemic therapy procedure was performed. A systemic therapy procedure is a medical, surgical or radiation procedure that has an effect on the hormonal or immunologic balance of the patient, and refers to haematologic transplant and endocrine procedures. Haematologic transplants are bone marrow or stem cell transplants performed to protect patients from myelosuppression or bone marrow ablation associated with the administration of high-dose chemotherapy or radiotherapy. Endo...
Standard: Health

Tissue sample collected indicator

545517 | Property | Cancer Australia
An indicator of whether a tissue sample has been collected.
Standard: Health

Performance status score at diagnosis

412353 | Property | Cancer Australia
A score given at the time of diagnosis outlining the extent to which a person’s disease affects their daily living abilities. This is based on assessment by a treating health professional. Performance status at diagnosis is an important prognostic indicator which is used to determine appropriate treatment, assess how the disease has progressed, and for the statistical analyses of outcome adjusted by performance status.
Standard: Health

Chemotherapy start date

413837 | Property | Cancer Australia
The date on which chemotherapy commenced. Chemotherapy is the treatment of disease by means of chemical substances or drugs; usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are administered in tr...
Standard: Health

Treatment plan modification

425598 | Property | Cancer Australia
A change to a treatment plan, often as a result of a response to treatment or a change in the extent or pathway of the disease.
Standard: Health

Variation from planned treatment indicator

468358 | Property | Cancer Australia
An indicator of whether the course of treatment for cancer received varied from the planned treatment. This includes the cessation of treatment and variation of the treatment type, delivery and/or dose.
Standard: Health

Second-line treatment type

432399 | Property | Cancer Australia
The type of second-line treatment administered for a disease.
Standard: Health

Castrate resistance date

587559 | Property | Cancer Australia
The date that two consecutive rising prostate-specific antigen levels (PSA) were found despite castrate levels of testosterone.
Standard: Health

Prostate-specific antigen test level

481433 | Property | Cancer Australia
The level of prostate-specific antigen (PSA) in the blood stream.
Standard: Health

Faecal incontinence indicator

481973 | Property | Cancer Australia
An indicator of whether a person is experiencing faecal incontinence.
Standard: Health

Treatment funding source

457099 | Property | Cancer Australia
The source of funding for a health-related treatment procedure or course of treatment.
Standard: Health

External beam radiotherapy type

468066 | Property | Cancer Australia
The type of external beam radiotherapy (XRT). The radiotherapy type relates to the planning target volume (PTV), the imaging type, and the radiotherapy beam arrangement.
Standard: Health

Extraprostatic extension focality

495226 | Property | Cancer Australia
The focality of extraprostatic extension (EPE) on the prostate.
Standard: Health

Multiple primary tumours indicator

519542 | Property | Cancer Australia
An indicator of whether multiple primary tumours are present.
Standard: Health

Date of treatment outcome

572842 | Property | Cancer Australia
The date on which the outcome of a course of treatment provided for a particular condition is recorded.
Standard: Health

Late effect type

573455 | Property | Cancer Australia
The type of late effect experienced due to a disease and/or the associated treatment.
Standard: Health

Basis of diagnostic investigation

431353 | Property | Cancer Australia
The basis of diagnostic investigation at the time of first presentation. This relates to whether the patient was symptomatic at the time of first presentation, and if not, what first initiated the process of investigations leading to diagnosis.A symptom is any morbid phenomenon or departure from the normal in structure, function or sensation experienced by the patient and indicative of disease.
Standard: Health

Core biopsy length

587536 | Property | Cancer Australia
The total length of biopsy cores collected from a single tissue specimen in pathology testing of a tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Reason(s) treatment not administered

428269 | Property | Cancer Australia
The reason(s) treatment was not administered for a particular condition or disease.
Standard: Health

Molecular pathology test results

428389 | Property | Cancer Australia
The results of a molecular pathology test for genetic and molecular abnormalities. In a clinical environment these results will inform the appropriate patient treatment pathway.
Standard: Health

Pelvic lymph node dissection laterality

494382 | Property | Cancer Australia
The laterality of the dissection of a pelvic lymph node for the purpose of determining lymph node metastasis in cancer. This procedure is most commonly used in prostate and bladder cancers.
Standard: Health

Psychosocial services type

519999 | Property | Cancer Australia
The type of psychosocial service a person is referred to as part of their cancer treatment or follow-up.
Standard: Health

Surgical margin qualifier

433045 | Property | Cancer Australia
The orientation of the surgical margin that is closest to the invasive or in situ carcinoma. Surgical margins represent sites that have either been cut or bluntly dissected by the surgeon to resect the specimen. The distance and orientation of the closest margin is useful for surgical audit and for assessing the completeness of surgical resection. Margin involvement may influence treatment decisions and is a prognostic indicator.
Standard: Health

Treatment complication outcome

581126 | Property | Cancer Australia
The outcome of an immediate or short-term treatment complication (adverse event) during clinical care.This includes, but is not limited to, complications from surgical treatment, such as an unplanned return to theatre, infection or haemorrhage, or complication from drug treatment, such as hypertension or toxicity.
Standard: Health

Lymphovascular invasion type

430038 | Property | Cancer Australia
The type of invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Distant metastatic cancer indicator

545183 | Property | Cancer Australia
An indicator of the existence of distant metastatic cancer. This may be determined through diagnostic or other imaging or procedures. Metastatic cancer is cancer which has spread from the initial site where it developed to other areas of the body. Which anatomical location is determined as a distant site will vary depending on the primary cancer type. Metastatic cancer is generally more common in aggressive cancer types and cancer which is left untreated for a longer period of time.
Standard: Health

Diagnosis date of first recurrence as locoregional cancer

447405 | Property | Cancer Australia
The date of first recurrence as locoregional cancer. The term recurrence defines the return, reappearance or metastasis of cancer (of the same histology) after a disease free period. Locoregional recurrence refers to the recurrence of cancer cells at the same site as the original (primary) tumour or the regional lymph nodes after a disease free period.
Standard: Health

Androgen deprivation therapy indicator

587574 | Property | Cancer Australia
An indicator of the use of androgen deprivation therapy to reduce androgen hormones. This includes both chemical and surgical treatments.
Standard: Health

Primary course of chemotherapy delay reason

450832 | Property | Cancer Australia
The reason for a delay in the primary course of chemotherapy.
Standard: Health

Erectile dysfunction assessment date

598102 | Property | Cancer Australia
The date that erectile dysfunction was assessed.
Standard: Health

Systemic therapy procedure

394647 | Property | Cancer Australia
The type of systemic therapy procedure used in treatment. A systemic therapy procedure is a medical, surgical or radiation procedure that has an effect on the hormonal or immunologic balance of the patient, and refers to haematologic transplant and endocrine procedures. Haematologic transplants are bone marrow or stem cell transplants performed to protect patients from myelosuppression or bone marrow ablation associated with the administration of high-dose chemotherapy or radiotherapy. Endocrine...
Standard: Health

Treatment complication type

546477 | Property | Cancer Australia
The type of short or long term treatment complication generally arising within 30 days of treatment.
Standard: Health

Immunotherapy completion date

393580 | Property | Cancer Australia
The date on which immunotherapy was completed. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Region of first recurrence as locoregional cancer

393844 | Property | Cancer Australia
The anatomical site of first recurrence as locoregional cancer. The term recurrence defines the return, reappearance or metastasis of cancer (of the same histology) after a disease free period. Locoregional recurrence refers to the recurrence of cancer cells at the same site as the original (primary) tumour or the regional lymph nodes after a disease free period.
Standard: Health

Specialist support services indicator

462091 | Property | Cancer Australia
An indicator of whether specialist support services are used as part of a patient's treatment regime. Specialist support services are those that do not target the primary disease but help to manage side effects, symptoms, late effects and quality of life. Specialist support services include community services, allied health services and other hospital support service, such as the use of psychiatrists, psychologists, physiotherapists, social workers, specialist nurses/nurse counsellors, cancer su...
Standard: Health

Shared care arrangement indicator

462731 | Property | Cancer Australia
An indicator of whether shared care arrangement is in place. A shared care arrangement is an agreement between specialists/hospitals and primary health practitioners to provide care for a specific health condition. This often involves a formal agreement between practitioners which includes the planned delivery of care and information exchange above routine referral notices.
Standard: Health

Tumour size outside primary site

425545 | Property | Cancer Australia
The size of the tumour extending outside of the primary site of cancer. This applies to both patients treated with and without surgery. In non-surgical cases, the extent of tumour outside the primary site may be assessed by imaging. For example, by using a CT scan, or ultrasound guided core biopsy.
Standard: Health

Post-initial surgery residual tumour size

425577 | Property | Cancer Australia
The size of the residual tumour remaining after the initial surgery for treatment purposes.
Standard: Health

Fertility counselling offered indicator

567255 | Property | Cancer Australia
An indicator of whether fertility counselling has been offered to an individual. This includes counselling about the potential outcomes of a disease, disorder or related treatment may have on long term fertility and the options in relation to fertility preservation or treatment options that may have a reduced impact on their fertility.
Standard: Health

Individual Healthcare Identifier

432483 | Property | Cancer Australia
An identifier allocated by Medicare Australia that uniquely identifies each individual in the Australian healthcare system.
Standard: Health

Location of lymphovascular invasion

545101 | Property | Cancer Australia
The location of the invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Positive biopsy core number

587527 | Property | Cancer Australia
The number of biopsy cores found positive for cancer in pathology testing of tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Systemic therapy agent or protocol

393613 | Property | Cancer Australia
The systemic therapy agent or protocol used for treatment. Systemic therapy agents are drugs that travel through the bloodstream and reach and effect cells all over the body. They are administered orally or intravenously. Systemic therapy agents may be administered as single-agent treatments or as a combination of drugs administered according to a prespecified regimen or protocol. A protocol is a precise and detailed plan for therapy that includes the type, quantity, method and length of time of...
Standard: Health

Tissue collection method

481989 | Property | Cancer Australia
The method used for the collection of a sample of tissue for pathology testing. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Fertility preservation procedure indicator

462737 | Property | Cancer Australia
An indicator of whether a procedure has been performed for the purpose of preserving fertility. This may include the preservation of fertility related tissue or biological material (sperm, eggs or embryos), and/or hormone treatments.
Standard: Health

Date of initial medical specialist consultation

456991 | Property | Cancer Australia
The date of the initial consultation with a medical specialist in relation to a specific disease-related symptom or suspected disease diagnosis.
Standard: Health

Late effect indicator

469616 | Property | Cancer Australia
An indicator of whether a late effect appears after the acute stage of a disease or condition has resolved. This is as a result of the treatment, the disease process, or both.
Standard: Health

Molecular pathology indicator

435162 | Property | Cancer Australia
An indicator of whether molecular pathology testing was performed to determine the characteristics of a person's medical condition.
Standard: Health

Date of referral to psychosocial services

448758 | Property | Cancer Australia
The date a patient was referred to psychosocial services.
Standard: Health

Diagnosis date of cancer

447400 | Property | Cancer Australia
The date on which cancer was first diagnosed.
Standard: Health

Chemotherapy cycles administered

393825 | Property | Cancer Australia
The number of cycles of chemotherapy administered. Chemotherapy is the treatment of disease by means of chemical substances or drugs; usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are administer...
Standard: Health

Radiotherapy start date

393479 | Property | Cancer Australia
The date on which radiotherapy commenced. Radiotherapy is the treatment of disease by means of ionizing radiation.
Standard: Health, WA Health

Cancer status

394063 | Property | Cancer Australia
Clinical evidence of the presence or absence of cancer. Clinical evidence describes the result of evaluation of a patient's physical condition and prognosis based on information gathered from physical examination, laboratory tests, imaging and the patient's medical history.
Standard: Health

Other cancer treatment

403842 | Property | Cancer Australia
Treatments used for the treatment of cancer other than surgery, radiotherapy or systemic therapy.
Standard: Health

Depth of myometrial invasion

425532 | Property | Cancer Australia
The depth of tumour invasion into the myometrium. The depth of myometrial invasion is assessed on microscopic examination and is measured from the normal endometrium-myometrium interface (not the surface of the intracavity or exophytic tumour) to the deepest tumour infiltrative focus.
Standard: Health

2 Next
Page size: